BioSpace News Archive

Castle Biosciences, Inc., a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, announced that Miles Harrison has been appointed to the board of directors, effective immediately, expanding the size of the board to eight members.

Veeva SiteVault Free allows sites to share and collaborate remotely with study monitors for source document review and verification

Helix BioPharma Corp.oday provides a corporate update.

Biomerica Inc. (NASDAQ: BMRA ) today announced it has signed two separate definitive license agreements with Mount Sinai’s Icahn School of Medicine in New York

Newly issued coverage statement on diagnostic platform for screening and surveillance of Barrett’s esophagus

Safety Review Committee for IV SB 11285 Phase 1a/1b trial recommends dose escalation to next planned dose level; initial patient dosed in next cohort

Mateon Therapeutics Inc. announced the publication of a peer-reviewed research article co-authored by Fatih Uckun MD PhD, Sanjive Qazi PhD, and Vuong Trieu, PhD in the oncology journal Cancer Reports and Reviews..

- The clinical study will evaluate the safety and preliminary efficacy of TJC4, in patients with relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - Initiation of development of TJC4 in China follows an ongoing Phase 1 study in U.S. for advanced solid tumors and lymphoma SHANGHAI, China, and ROCKVILLE, MD., April 02, 2020 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, d

CAS, a division of the American Chemical Society specializing in scientific information solutions, is partnering with research and technology organizations worldwide to tackle the complex challenges presented by COVID-19.

National Safety Council President & CEO Lorraine Martin issued the following call to business leaders across the country to take aggressive action to ensure employee safety from COVID-19.